January 5, 2012
Dyann House, a cancer trial participant at Phoebe Cancer Center, will continue to receive Herceptin for a full year. House, who will be part of the study for an additional 20 years, said she is glad to be a part of something that will help women all over the world.
Stories this photo appears in:
Phoebe cancer trials help patients
Cooperation of patients treated at the Phoebe Cancer Center gives physicians everywhere tools and information to treat the disease.
Comments
Use the comment form below to begin a discussion about this content.
Sign in to comment